| |
| |
|
| Insider
Information: |
Meyers James R |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
54,993 |
|
|
Indirect Shares
|
132,083 |
|
|
| Direct
Value |
$391,959 |
|
|
|
Indirect Value
|
$8,963,152 |
|
|
| Total
Shares |
187,076 |
|
|
| Total
Value |
$9,355,112 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP Worldwide Commerci... |
2018-02-21 |
5,393 |
2018-02-21 |
132,083 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Director |
2023-06-01 |
49,600 |
2019-11-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
SVP Comm Ops North AmericaOffi |
• – – |
2007-01-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,029 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP Comm Ops North America |
• – – |
2007-02-28 |
4 |
OE |
$7.08 |
$49,266 |
D/D |
6,000 |
7,029 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP Comm Ops North America |
• – – |
2007-02-28 |
4 |
S |
$71.35 |
$428,088 |
D/D |
(6,000) |
1,029 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP Comm Ops North America |
• – – |
2007-04-24 |
4 |
OE |
$7.40 |
$66,587 |
D/D |
9,000 |
10,029 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP Comm Ops North America |
• – – |
2007-04-24 |
4 |
S |
$83.09 |
$748,584 |
D/D |
(9,000) |
1,029 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial OpsOf |
• – – |
2016-11-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
121,151 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial OpsOf |
• – – |
2016-11-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,726 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$12,637 |
D/D |
213 |
6,939 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-02-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,354 |
125,505 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,354 |
2,715 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$144,346 |
D/D |
(2,053) |
7,069 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,183 |
9,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
820 |
3,535 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-10 |
4 |
D |
$72.70 |
$21,447 |
D/D |
(295) |
3,240 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
525 |
2,715 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
525 |
126,030 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
115 |
126,145 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
115 |
2,715 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-15 |
4 |
A |
$59.76 |
$6,873 |
D/D |
115 |
2,830 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-31 |
4 |
OE |
$21.00 |
$1,260,000 |
D/D |
60,000 |
62,715 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-08-31 |
4 |
S |
$83.01 |
$4,991,290 |
D/D |
(60,000) |
2,715 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-11-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,288 |
128,433 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-11-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,288 |
2,715 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-11-05 |
4 |
D |
$73.46 |
$162,494 |
D/D |
(2,212) |
5,003 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Worldwide Commercial Ops |
• • – |
2017-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
7,215 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
